Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies
- PMID: 21073310
- PMCID: PMC3527891
- DOI: 10.2217/fmb.10.107
Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies
Abstract
Human papillomaviruses (HPVs) cause diseases ranging from benign warts to invasive tumors. A subset of these viruses termed 'high risk' infect the cervix where persistent infection can lead to cervical cancer. Although many HPV genomes have been sequenced, knowledge of virus gene expression and its regulation is still incomplete. This is due in part to the lack, until recently, of suitable systems for virus propagation in the laboratory. HPV gene expression is polycistronic initiating from multiple promoters. Gene regulation occurs at transcriptional, but particularly post-transcriptional levels, including RNA processing, nuclear export, mRNA stability and translation. A close association between the virus replication cycle and epithelial differentiation adds a further layer of complexity. Understanding HPV mRNA expression and its regulation in the different diseases associated with infection may lead to development of novel diagnostic approaches and will reveal key viral and cellular targets for development of novel antiviral therapies.
Figures
References
-
- zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virol. 2009;384:260–5. - PubMed
-
- de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virol. 2004;324:17–24. - PubMed
-
- Stanley MA. Human papillomavirus vaccines. Rev. Med. Virol. 2006;16:139–49. - PubMed
-
- Doorbar J, Foo C, Coleman N, et al. Characterisation of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virol. 1997;238:40–52. - PubMed
-
- Graham SV. Late events in the life cycle of human papillomaviruses. In: Campo MS, editor. Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press; Wymondham, Norfolk: 2006. pp. 193–212.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources